The activation of each clinical trial involves hundreds of tasks, along with many dependencies and handoffs, some of which may be automated, but many require manual processes.
Amplifying the size and diversity of participant pools in clinical trials enhances statistical power and increases the generalizability of study findings.
Similar to a world-class symphony, a curated site start-up model can accentuate its individual components and lead to swift starts for clinical trials.
Sujay Jadhav, global vice president, study start-up, Oracle Health Sciences, spoke with ACT on how study start-up has been impacted by the pandemic and what its future holds beyond COVID.